The SMART Protocol in Mesothelioma: Challenges and Opportunities for Global Adoption
John Cho, MD, PhD, FRCPC
Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing
CAR T in Marginal Zone Lymphoma: Insights from the TRANSCEND FL Study
Charles Turck, PharmD, BCPS, BCCCP
Sairah Ahmed, MD
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Immunotherapy Advances in Squamous Cell Anal Carcinoma: A New Standard of Care
Marwan G. Fakih, MD
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Balazs Halmos, MD, MS
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
The Evolving Treatment Landscape for Extrapulmonary Neuroendocrine Carcinomas
Namrata Vijayvergia, MD
SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Treating Gastrointestinal Neuroendocrine Carcinoma: Beyond Lung-Based Approaches
Diagnosing LCNEC of the Lung: Challenges and Strategies
Junaid Arshad, MD, MS
Personalizing Care for Large Cell Neuroendocrine Carcinoma
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
Studying Carboplatin-Paclitaxel + Retifanlimab for Squamous Cell Carcinoma of the Anal Canal
Richard Kim, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.